Adaptimmune Therapeutics
ADAP
#7773
Rank
NZ$0.36 B
Marketcap
$1.44
Share price
-1.20%
Change (1 day)
28.20%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: NZ$0.36 Billion

As of October 2024 Adaptimmune Therapeutics has a market cap of NZ$0.36 Billion. This makes Adaptimmune Therapeutics the world's 7773th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.36 B29.57%
2023NZ$0.28 B-24.4%
2022NZ$0.37 B-56.07%
2021NZ$0.85 B-25.84%
2020NZ$1.15 B517.08%
2019NZ$0.18 B-79.1%
2018NZ$0.89 B1.73%
2017NZ$0.88 B112.92%
2016NZ$0.41 B-66.82%
2015NZ$1.24 B

End of Day market cap according to different sources

On Oct 10th, 2024 the market cap of Adaptimmune Therapeutics was reported to be:

NZ$0.36 Billion
by Yahoo Finance info icon info icon
NZ$0.36 Billion
by CompaniesMarketCap info icon info icon
NZ$0.36 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$3.39 B 819.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$94.6 M-74.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.43 B 17.41%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$12.03 B 3,162.38%๐Ÿ‡บ๐Ÿ‡ธ USA